TIMP蛋白家族:在病理生理学中的多样性作用
Sasha Coates-Park1, Joshua A Rich1, William G Stetler-Stevenson1
1Extracellular Matrix Pathology Section, Laboratory of Pathology, National Cancer Institute, National Institute of Health, Bethesda, Maryland, United States.
American journal of physiology. Cell physiology
|January 29, 2024
概括
基质金属蛋白酶的组织抑制剂 (TIMPs) 是关键蛋白质,其作用不仅仅是抑制金属蛋白酶. 本综述探讨了它们在各种疾病中的多样化功能和治疗潜力.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 矩阵金属蛋白酶的组织抑制剂 (TIMPs) 是一个由四种蛋白质组成的家族.
- 传统上被认为是金属蛋白酶 (MP) 的内源抑制剂.
- 具有重要的金属蛋白酶独立功能.
研究的目的:
- 提供TIMP功能的全面概述.
- 探索TIMP的MP依赖和MP独立的角色.
- 考虑TIMPs在病理条件下的治疗和生物标志物潜力.
主要方法:
- 文献综述. 这是一个文献综述.
- 对TIMP现有的研究进行了全面的分析.
- 对TIMP功能和应用程序的数据的综合.
主要成果:
- 除了MP抑制之外,TIMPs表现出各种生物功能,包括在炎症和亡中的作用.
- TIMPs涉及到广泛的病理生理学背景.
- 每个TIMP家族成员都有独特的MP依赖和独立活动.
结论:
- 在健康和疾病方面,TIMPs具有多方面的作用.
- 作为治疗剂和生物标志物,TIMPs具有显著的前景.
- 对于生物医学应用,对TIMP生物学进行进一步的研究是有必要的.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


